Case Reports in Pulmonology / 2020 / Article / Fig 1

Case Report

Azathioprine Hypersensitivity Syndrome during Treatment of Severe Interstitial Lung Disease with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Figure 1

WBC, CRP, and Cr levels at about 4 months after the start of AZA and trends in PSL and AZA medication doses. Blood test results for the days indicated by the bold arrow are shown in Table 1. AZA: azathioprine; PSL: prednisolone.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.